[8] Another potential serious effect is hemolytic anemia (breakdown of red blood cells) in individuals with G6PD deficiency, but those individuals shouldnt be on MB in the first place
This can come in the form of injections or oral alternatives
By drug class, the Glucagon like peptide-1 (GLP-1) receptor agonist segment is accounted for a 41.9% revenue share in 2023
doi: 10.1016/j.jogoh.2024.102723 61 BuggioLDridiDBarbaraGMerliCCeteraGVercelliniP
FOXO3a acetylation regulates PINK1, mitophagy, inflammasome activation in murine palmitate-conditioned and diabetic macrophages
Oxidative stress levels vary among patients, and identifying reliable biomarkers (e.g., isoprostanes, nitrotyrosine, mitochondrial DNA) could allow stratification of patients who are most likely to benefit from antioxidant treatment